Joag, V., Obila, O., Gajer, P., et al. Impact of standard bacterial vaginosis treatment on the genital mirobiota, immune milieu, and ex vivo human immunodeficiency virus susceptibility. Clin. Inf. Dis. p. 1-9, 2018.
Last Updated On Monday, February 4, 2019 by Malenka, Judith Ann
Created On Friday, January 11, 2019